|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/30/15 Solarcity Corp 10-Q 6/30/15 87:18M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.01M
2: EX-10.10K Material Contract HTML 82K
3: EX-10.16E Material Contract HTML 36K
4: EX-10.19 Material Contract HTML 948K
5: EX-10.19A Material Contract HTML 45K
6: EX-10.19B Material Contract HTML 1.00M
7: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
8: EX-31.2 Certification -- §302 - SOA'02 HTML 32K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 29K
10: EX-32.2 Certification -- §906 - SOA'02 HTML 29K
60: R1 Document and Entity Information HTML 47K
47: R2 Condensed Consolidated Balance Sheets HTML 171K
58: R3 Condensed Consolidated Balance Sheets HTML 100K
(Parenthetical)
62: R4 Condensed Consolidated Statements of Operations HTML 108K
(Unaudited)
81: R5 Condensed Consolidated Statements of Cash Flows HTML 161K
49: R6 Organization HTML 32K
57: R7 Summary of Significant Accounting Policies and HTML 193K
Procedures
43: R8 Goodwill and Intangible Assets HTML 319K
33: R9 Selected Balance Sheet Components HTML 163K
82: R10 Indebtedness HTML 398K
64: R11 VIE Arrangements HTML 250K
63: R12 Financing Obligations HTML 35K
69: R13 Redeemable Noncontrolling Interests in HTML 43K
Subsidiaries
70: R14 Equity HTML 85K
67: R15 Equity Award Plans HTML 266K
71: R16 Income Taxes HTML 37K
59: R17 Related Party Transactions HTML 102K
61: R18 Commitments and Contingencies HTML 52K
66: R19 Basic and Diluted Net Loss Per Share HTML 120K
87: R20 Subsequent Events HTML 30K
77: R21 Summary of Significant Accounting Policies and HTML 227K
Procedures (Policies)
53: R22 Summary of Significant Accounting Policies and HTML 166K
Procedures (Tables)
65: R23 Goodwill and Intangible Assets (Tables) HTML 318K
55: R24 Selected Balance Sheet Components (Tables) HTML 163K
25: R25 Indebtedness (Tables) HTML 358K
78: R26 VIE Arrangements (Tables) HTML 246K
84: R27 Redeemable Noncontrolling Interests in HTML 40K
Subsidiaries (Tables)
37: R28 Equity (Tables) HTML 79K
36: R29 Equity Award Plans (Tables) HTML 266K
40: R30 Related Party Transactions (Tables) HTML 99K
41: R31 Basic and Diluted Net Loss Per Share (Tables) HTML 121K
44: R32 Organization - Additional Information (Detail) HTML 29K
23: R33 Summary of Significant Accounting Policies and HTML 94K
Procedures - Additional Information (Detail)
75: R34 Summary of Significant Accounting Policies and HTML 52K
Procedures - Assets and Liabilities Carried at
Fair Value on Recurring Basis (Detail)
51: R35 Summary of Significant Accounting Policies and HTML 32K
Procedures - Summary of the Activity of the Level
3 Contingent Consideration (Detail)
54: R36 Summary of Significant Accounting Policies and HTML 40K
Procedures - Schedule of Estimated Fair Values and
Carrying Values (Detail)
28: R37 Summary of Significant Accounting Policies and HTML 35K
Procedures - Summary of MyPower Deferred Revenue
Activity (Detail)
86: R38 Summary of Significant Accounting Policies and HTML 34K
Procedures - Summary of MyPower Deferred Cost
Activity (Detail)
17: R39 Summary of Significant Accounting Policies and HTML 30K
Procedures - Summary of MyPower Deferred Cost
Activity (Parenthetical) (Detail)
45: R40 Summary of Significant Accounting Policies and HTML 35K
Procedures - Schedule of Changes in Accrued
Warranty Balance (Detail)
80: R41 Goodwill and Intangible Assets - Summary of HTML 68K
Intangible Assets (Detail)
27: R42 Goodwill and Intangible Assets - Amortization HTML 40K
Expense for Identifiable Purchased Intangible
Assets (Detail)
35: R43 Goodwill and Intangible Assets - Additional HTML 32K
Information (Detail)
39: R44 Goodwill and Intangible Assets - Summary of HTML 52K
Expected Future Amortization Expense for
Intangible Assets (Detail)
48: R45 Selected Balance Sheet Components - Components of HTML 101K
Condensed Consolidated Balance Sheet (Detail)
22: R46 Selected Balance Sheet Components - Components of HTML 35K
Condensed Consolidated Balance Sheet
(Parenthetical) (Detail)
32: R47 Indebtedness - Summary of Debt (Detail) HTML 135K
19: R48 Indebtedness - Additional Information (Detail) HTML 248K
79: R49 VIE Arrangements - Summary of Number of Current HTML 51K
VIE Funds by Classification of Investor, the
Carrying Value, Total Investor Contributions
Received and Undrawn Investor Contributions
(Detail)
26: R50 VIE Arrangements - Additional Information (Detail) HTML 42K
76: R51 VIE Arrangements - Carrying Values of Assets and HTML 112K
Liabilities of Subsidiary in Consolidated Balance
Sheets (Detail)
29: R52 Financing Obligations - Additional Information HTML 32K
(Detail)
46: R53 Redeemable Noncontrolling Interests in HTML 46K
Subsidiaries - Activity of Redeemable
Noncontrolling Interests in Subsidiaries (Detail)
18: R54 Equity - Schedule of Changes in Total HTML 54K
Stockholders' Equity and Noncontrolling Interests
(Detail)
21: R55 Equity Award Plans - Additional Information HTML 75K
(Detail)
38: R56 Equity Award Plans - Summary of Stock Option HTML 79K
Activity (Detail)
24: R57 Equity Award Plans - Summary of Stock Option HTML 30K
Activity (Parenthetical) (Detail)
83: R58 Equity Award Plans - Summary of Fair Value of HTML 39K
Stock Options Granted Using Weighted-Average
Assumptions (Detail)
50: R59 Equity Award Plans - Summary of RSU Activity HTML 54K
(Detail)
68: R60 Equity Award Plans - Summary of Stock-Based HTML 40K
Compensation Expense Capitalized (Detail)
31: R61 Equity Award Plans - Summary of Stock-Based HTML 41K
Compensation Expense Recognized (Detail)
34: R62 Income Taxes - Additional Information (Detail) HTML 35K
74: R63 Related Party Transactions - Components of Related HTML 39K
Party Transactions (Detail)
72: R64 Related Party Transactions - Summary of Related HTML 43K
Party Balances (Detail)
52: R65 Commitments and Contingencies - Additional HTML 70K
Information (Detail)
73: R66 Basic and Diluted Net Loss per Share - Computation HTML 54K
of Company's Basic and Diluted Net Loss Per Share
(Detail)
30: R67 Basic and Diluted Net Loss per Share - Schedule of HTML 39K
Weighted-Average Outstanding Shares of Common
Stock Equivalents Excluded from Computation of
Diluted Net Loss Per Share (Detail)
56: R68 Subsequent Events - Additional Information HTML 36K
(Detail)
85: XML IDEA XML File -- Filing Summary XML 151K
20: EXCEL IDEA Workbook of Financial Reports XLSX 98K
11: EX-101.INS XBRL Instance -- scty-20150630 XML 4.72M
13: EX-101.CAL XBRL Calculations -- scty-20150630_cal XML 215K
14: EX-101.DEF XBRL Definitions -- scty-20150630_def XML 739K
15: EX-101.LAB XBRL Labels -- scty-20150630_lab XML 1.37M
16: EX-101.PRE XBRL Presentations -- scty-20150630_pre XML 1.08M
12: EX-101.SCH XBRL Schema -- scty-20150630 XSD 208K
42: ZIP XBRL Zipped Folder -- 0001564590-15-005816-xbrl Zip 230K
Exhibit 10.16e
FIFTH AMENDMENT TO AMENDED AND RESTATED AGREEMENT FOR RESEARCH & DEVELOPMENT ALLIANCE ON
TRIEX MODULE TECHNOLOGY
This FIFTH AMENDMENT TO AMENDED AND RESTATED AGREEMENT FOR RESEARCH & DEVELOPMENT ALLIANCE ON TRIEX MODULE TECHNOLOGY (this “Amendment”) is effective as of June 30, 2015 (the “Effective Date”) and is by and between THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (“FOUNDATION”), a non-profit educational corporation existing under the laws of the State of New York, having an office located at 257 Fuller Road, Albany, New York 12203, on behalf of the Colleges of Nanoscale Science and Engineering of the State University of New York Polytechnic Institute), and SILEVO, LLC (“SILEVO”), a Delaware corporation with its principal office located at 45655 Northport Loop East, Fremont, California 94555. FOUNDATION and SILEVO are each referred to herein sometimes individually as a “Party” or, collectively, as “Parties.”
I. RECITALS
I.1.FOUNDATION and SILEVO entered into that certain Amended and Restated Agreement for Research & Development Alliance on Triex Module Technology effective as of September 2, 2014, as amended by a First Amendment thereto effective as of October 31, 2014, a Second Amendment thereto effective as of December 15, 2014, a Third Amendment thereto effective as of February 12, 2015 and a Fourth Amendment thereto effective as of March 30, 2015 (as amended, the “Agreement”).
I.2.The parties wish to amend the terms of Section 19.14 of the Agreement as set forth in this Amendment.
THEREFORE, in consideration of the mutual promises and covenants contained in this Amendment and other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, and intending to be legally bound hereby, the Parties agree as follows:
II. DEFINED TERMS
In addition to the terms defined elsewhere in this Amendment, capitalized terms that are used but not defined herein shall have the meanings ascribed to such terms in the Agreement.
III. AMENDMENTS
Section 19.14 is amended by deleting the reference to “June 30, 2015” and replacing it with “August 31, 2015”.
IV. MISCELLANEOUS
|
representations, and understandings, either oral or written, between the Parties or any officers, agents or representatives thereof. This Amendment may be signed in one or more counterparts, each of which shall be deemed to be an original and all of which when taken together shall constitute the same Amendment. Any signed copy of this Amendment made by photocopy, facsimile or PDF Adobe format shall be considered an original. Except as amended and/or modified by this Amendment, the Agreement is hereby ratified and confirmed and the Agreement and all other terms thereof shall remain in full force and effect, unaltered and unchanged by this Amendment. In the event of any conflict between the provisions of this Amendment and the provisions of the Agreement, the provisions of this Amendment shall prevail. Whether or not specifically amended by this Amendment, all of the terms and provisions of the Agreement are hereby amended to the extent necessary to give effect to the purpose and intent of this Amendment. |
IN WITNESS WHEREOF, the Parties hereto have caused this Amendment to be executed and delivered by their duly authorized representatives as of the Effective Date.
THE RESEARCH FOUNDATION FOR
THE STATE UNIVERSITY OF NEW YORK
By: /s/Christine Waller
Name: Christine Waller
Title: Operations Manager
SILEVO, LLC
By: /s/ Zheng Zu
Name: Zheng Zu
Title: CEO, Silevo LLC
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 8/31/15 | 424B5, 8-K | |||
| Filed on: | 7/30/15 | |||
| For Period end: | 6/30/15 | |||
| 3/30/15 | 424B5, 8-K, FWP | |||
| 2/12/15 | ||||
| 12/15/14 | ||||
| 10/31/14 | ||||
| 9/2/14 | 4 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/29/24 Tesla, Inc. 10-K 12/31/23 116:14M Workiva Inc Wde… FA01/FA 1/31/23 Tesla, Inc. 10-K 12/31/22 125:30M Donnelley … Solutions/FA 5/02/22 Tesla, Inc. 10-K/A 12/31/21 12:2.6M ActiveDisclosure/FA 2/07/22 Tesla, Inc. 10-K 12/31/21 131:28M Donnelley … Solutions/FA 4/30/21 Tesla, Inc. 10-K/A 12/31/20 12:2.3M ActiveDisclosure/FA 2/08/21 Tesla, Inc. 10-K 12/31/20 149:31M ActiveDisclosure/FA |